Skip to main content

Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial.

Publication ,  Journal Article
Weir, MR; Gravens-Muller, L; Costa, N; Ivanova, A; Manitpisitkul, W; Bostom, AG; Diamantidis, CJ; FAVORIT Study Investigators,
Published in: Transplantation
May 2015

BACKGROUND: Kidney transplant recipients are at increased risk for adverse safety events related to their reduced renal function and many medications. METHODS: We determined the incidence of adverse safety events based on previously defined Agency for Healthcare and Research Quality (AHRQ) International Classification of Diseases-9 (ICD-9) code-derived patient safety indicators (PSI) in the Folic Acid for Vascular Outcome Reduction in Transplant trial participants who had a hospitalization stratified by tertiles of estimated glomerular filtration rate (GFR). We also examined the frequency of Micromedex defined two precautionary drug-drug interactions, and two medications whose use may be contraindicated because of reduced GFR from the Folic Acid for Vascular Outcome Reduction in Transplant trial medication thesaurus at baseline, and annually among 4,110 participants. Logistic regression was used to examine the relationship between patient safety events and baseline demographic and clinical variables at a participant level. Event rates were estimated at participant and visit levels. RESULTS: Of the 2,514 patients with a hospitalization, 978 (38.9%) experienced an AHRQ PSI. Factors which were associated with more common AHRQ PSI included: U.S. location, history of cardiovascular disease or diabetes, and lower tertile of estimated GFR. At a participant level, 2,524 of the 4,110 participants (61.4%) were taking calcineurin inhibitor and statin, 378 (9.2%) were taking azathioprine and an angiotensin-converting enzyme inhibitor, 171 (12.9%) were taking a sulfonylurea), 45 (3.4%) were taking metformin despite a baseline GFR below 40 mL per min per 1.73 m. CONCLUSION: We conclude that patient safety events are not uncommon in kidney transplant recipients. Careful monitoring is necessary to prevent adverse outcomes.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Transplantation

DOI

EISSN

1534-6080

Publication Date

May 2015

Volume

99

Issue

5

Start / End Page

1003 / 1008

Location

United States

Related Subject Headings

  • Surgery
  • Patient Safety
  • Middle Aged
  • Metformin
  • Male
  • Kidney Transplantation
  • Humans
  • Glomerular Filtration Rate
  • Folic Acid
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Weir, M. R., Gravens-Muller, L., Costa, N., Ivanova, A., Manitpisitkul, W., Bostom, A. G., … FAVORIT Study Investigators, . (2015). Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial. Transplantation, 99(5), 1003–1008. https://doi.org/10.1097/TP.0000000000000454
Weir, Matthew R., Lisa Gravens-Muller, Nadiesda Costa, Anastasia Ivanova, Wana Manitpisitkul, Andrew G. Bostom, Clarissa J. Diamantidis, and Clarissa J. FAVORIT Study Investigators. “Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial.Transplantation 99, no. 5 (May 2015): 1003–8. https://doi.org/10.1097/TP.0000000000000454.
Weir MR, Gravens-Muller L, Costa N, Ivanova A, Manitpisitkul W, Bostom AG, et al. Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial. Transplantation. 2015 May;99(5):1003–8.
Weir, Matthew R., et al. “Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial.Transplantation, vol. 99, no. 5, May 2015, pp. 1003–08. Pubmed, doi:10.1097/TP.0000000000000454.
Weir MR, Gravens-Muller L, Costa N, Ivanova A, Manitpisitkul W, Bostom AG, Diamantidis CJ, FAVORIT Study Investigators. Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial. Transplantation. 2015 May;99(5):1003–1008.

Published In

Transplantation

DOI

EISSN

1534-6080

Publication Date

May 2015

Volume

99

Issue

5

Start / End Page

1003 / 1008

Location

United States

Related Subject Headings

  • Surgery
  • Patient Safety
  • Middle Aged
  • Metformin
  • Male
  • Kidney Transplantation
  • Humans
  • Glomerular Filtration Rate
  • Folic Acid
  • Female